Abstract |
Meningococcal septic shock (MSS) has high mortality and morbidity rates. In addition to the traditional prompt antibiotics and respiratory and circulatory support, new treatment strategies have been proposed. AGAINST THE INFLAMMATORY CASCADE: TO TREAT HEMOSTATIC ABNORMALITIES: TO INDUCE VASODILATION: OTHER STRATEGIES: CONCLUSIONS: There is no proof that unconventional treatments have a significant impact on outcome in MSS; prospective multicenter trials are needed. At present, early recognition of meningococcal sepsis and appropriate treatment seem to be the optimal methods of improving outcome. Efforts to find an effective meningococcal vaccine must be continued.
|
Authors | F Leclerc, S Leteurtre, R Cremer, C Fourier, A Sadik |
Journal | Critical care medicine
(Crit Care Med)
Vol. 28
Issue 9 Suppl
Pg. S60-3
(Sep 2000)
ISSN: 0090-3493 [Print] United States |
PMID | 11007200
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Bacteremia
(therapy)
- Hemofiltration
- Hemostasis
(drug effects)
- Humans
- Hyperbaric Oxygenation
- Meningococcal Infections
(therapy)
- Vasodilator Agents
(therapeutic use)
|